Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Hepatocellular CarcinomaGastrointestinal Cancer MetastaticNeuroendocrine Tumors

Interventions

DRUG

Tirapazamine

Intra-arterial injection into the tumor feeding artery

PROCEDURE

Conventional Transarterial Embolization (TAE)

Lipiodol and Gelfoam used to embolize tumor vessels and induce tumor hypoxia

Trial Locations (2)

RECRUITING

University of Pennsylvania, Philadelphia

RECRUITING

Stanford University, Palo Alto

All Listed Sponsors

lead

Teclison Ltd.

INDUSTRY

NCT02174549 - Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer | Biotech Hunter | Biotech Hunter